T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.79B |
| 2 |
PayPal
PYPL
|
+$1.64B |
| 3 |
Alibaba
BABA
|
+$1.46B |
| 4 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$1.11B |
| 5 |
Johnson Controls International
JCI
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$8.15B |
| 2 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$1.77B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.74B |
| 4 |
Danaher
DHR
|
+$1.54B |
| 5 |
GE Aerospace
GE
|
+$1.26B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.56% |
| 2 | Consumer Discretionary | 15.28% |
| 3 | Financials | 14.93% |
| 4 | Technology | 13.43% |
| 5 | Communication Services | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
PUT
JPMorgan Chase
JPM
$965B
| $23.3M | ﹤0.01% |
350,000
| – | – |
|
1077
Oil-Dri
ODC
$1.27B
| $23.2M | ﹤0.01% |
1,232,660
+1,960
| +0.2% | +$36.3K |
|
|
SIX
1078
DELISTED
Six Flags Entertainment Corp.
SIX
| $23.1M | ﹤0.01% |
431,484
+42,710
| +11% | +$2.3M |
|
|
CATM
1079
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $23M | ﹤0.01% |
515,964
+48,000
| +10% | +$2.11M |
|
1080
Dover
DOV
$27.8B
| $22.8M | ﹤0.01% |
383,024
+2,632
| +0.7% | +$152K |
|
1081
Seagate
STX
$209B
| $22.8M | ﹤0.01% |
590,740
-753,571
| -56% | -$24.5M |
|
1082
Luxfer Holdings
LXFR
$457M
| $22.7M | ﹤0.01% |
1,960,930
| – | – |
|
1083
Arthur J. Gallagher & Co
AJG
$65B
| $22.7M | ﹤0.01% |
445,540
+128,410
| +40% | +$6.34M |
|
1084
Wynn Resorts
WYNN
$10.5B
| $22.7M | ﹤0.01% |
232,551
+15,000
| +7% | +$1.46M |
|
1085
Golub Capital BDC
GBDC
$3.48B
| $22.6M | ﹤0.01% |
1,242,067
+3,461
| +0.3% | +$63.4K |
|
|
AKRX
1086
DELISTED
Akorn Inc
AKRX
| $22.6M | ﹤0.01% |
828,677
+68,965
| +9% | +$2.04M |
|
|
GCP
1087
DELISTED
GCP Applied Technologies Inc.
GCP
| $22.6M | ﹤0.01% |
796,789
+125,720
| +19% | +$3.49M |
|
|
LLL
1088
DELISTED
L3 Technologies, Inc.
LLL
| $22.5M | ﹤0.01% |
149,444
+8,789
| +6% | +$1.31M |
|
1089
CMS Energy
CMS
$22.1B
| $22.4M | ﹤0.01% |
533,181
+10
| +0% | +$437 |
|
1090
F5
FFIV
$23.6B
| $22.4M | ﹤0.01% |
179,505
-400
| -0.2% | -$48.6K |
|
|
SYNH
1091
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $22.3M | ﹤0.01% |
500,505
+146,735
| +41% | +$6.36M |
|
1092
Orion
OEC
$360M
| $22.3M | ﹤0.01% |
+1,190,334
| New | +$20.8M |
|
1093
Coherus Oncology
CHRS
$176M
| $22.3M | ﹤0.01% |
+831,322
| New | +$22.7M |
|
|
STRZA
1094
DELISTED
Starz - Series A
STRZA
| $22.1M | ﹤0.01% |
708,316
+20,624
| +3% | +$636K |
|
1095
Chemed
CHE
$7.02B
| $22.1M | ﹤0.01% |
156,395
+15,145
| +11% | +$2.11M |
|
1096
International Flavors & Fragrances
IFF
$21.4B
| $21.8M | ﹤0.01% |
152,507
+8,505
| +6% | +$1.15M |
|
1097
Masco
MAS
$14.7B
| $21.7M | ﹤0.01% |
632,739
-821,047
| -56% | -$28.4M |
|
1098
United Therapeutics
UTHR
$21.5B
| $21.5M | ﹤0.01% |
182,060
+15,254
| +9% | +$1.83M |
|
|
TEN
1099
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $21.5M | ﹤0.01% |
368,560
+51,920
| +16% | +$2.83M |
|
1100
Xencor
XNCR
$1.71B
| $21.4M | ﹤0.01% |
875,676
+300,360
| +52% | +$6.35M |
|
Similar funds
T. Rowe Price Associates's Q3 2016 Portfolio in Review
As of Q3 2016, T. Rowe Price Associates held 2,648 positions worth $498B, up 5.4% from $472B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
T. Rowe Price Associates's Q3 2016 filing shows 135 new, 1,180 increased, 817 reduced and 125 closed positions. Its largest new stake was Fortive: 55,770,886 shares worth $1.79B. The largest sale was TotalEnergies, an estimated $8.15B.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2016 buy was Fortive: 55,770,886 shares worth $1.79B.
- T. Rowe Price Associates added most to PayPal in Q3 2016, an estimated $1.64B increase.
- T. Rowe Price Associates's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $8.15B.
- T. Rowe Price Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2016, selling an estimated $1.77B.
- T. Rowe Price Associates's ten largest holdings make up 17% of its $498B portfolio in Q3 2016.
- T. Rowe Price Associates opened 135 new positions and closed 125 in Q3 2016.
- T. Rowe Price Associates's portfolio value rose 5.4% quarter-over-quarter to $498B.
Based on T. Rowe Price Associates's 13F filing for Q3 2016, filed 14 Nov 2016.